BCR and acute lymphoblastic leukemia: Further investigation of matrine on the MAPK/ERK-BCR/ABL-related signaling pathways would elucidate its molecular mechanisms underlying the anti-leukemic effects and its potential in the clinical therapy of CML and Ph+ ALL.